Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment

Table 2

Predictors of longitudinal cognitive performance variation over 36 weeks of follow-up

TMT-B RAVLT
β P value β P value
All participants (n = 97)
    Time −61.4730 0.134 5.9875 <0.001
    Age (years) 3.5150 0.004 −0.0988 0.012
    Group −25.5932 0.002 0.5240 0.048
    FPI 38.2203 0.129 −0.3998 0.715
    Time × FPI 18.0139 0.024 −2.2636 <0.001
MF/Rosi group (n = 32)
    Time −70.6536 0.189 0.7851 0.699
    Age (years) 1.2301 0.574 −0.0315 0.645
    FPI 49.0536 0.069 −0.4850 0.510
    Time × FPI 15.8370 0.064 −1.899 0.009
  • Each model was adjusted for the following covariates: sex, formal education, diabetes duration (years), depression, FPG, systolic blood pressure, BMI, triglycerides, and A1C.

This Article

  1. Diabetes Care vol. 33 no. 8 1706-1711